IMUX Stock Analysis: Buy, Sell, or Hold?

IMUX - Immunic, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.66
0.00 (0.28%) ▲
5d: +5.38%
30d: +12.47%
90d: -15.83%
BUY
HIGH Confidence
Last Updated: February 3, 2026
Earnings: Feb 19, 2026 14d

Get Alerted When IMUX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: IMUX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.

In-depth Analysis How we analyze

Valuation Analysis: IMUX is currently trading at $0.66, which is considered slightly high relative to its 30-day fair value range of $0.58 to $0.68.

Technical Outlook: Technically, IMUX is in a strong downtrend. Immediate support is located at $0.58, while resistance sits at $0.72.

Market Sentiment: IMUX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.38 (+719.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $0.58 - $0.68
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 78.9%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 719.7% below Wall St target ($5.38)

Fair Price Analysis

30-Day Fair Range $0.58 - $0.68
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $0.58
Resistance Level $0.72
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) -1.76
Wall Street Target $5.38 (+719.7%)
Last updated: February 04, 2026 9:13 AM ET
Data refreshes hourly during market hours. Next update: 10:13 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$24 56 HOLD
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1036 58 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$33 65 BUY
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$85 53 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD

More Analysis for IMUX

IMUX Technical Chart IMUX Price Prediction IMUX Earnings Date IMUX Investment Advisor IMUX Fair Price Analyzer IMUX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals